Alice Tsai

970 total citations
11 papers, 464 citations indexed

About

Alice Tsai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Alice Tsai has authored 11 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Organic Chemistry. Recurrent topics in Alice Tsai's work include Cancer-related gene regulation (3 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). Alice Tsai is often cited by papers focused on Cancer-related gene regulation (3 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). Alice Tsai collaborates with scholars based in United States, United Kingdom and Japan. Alice Tsai's co-authors include Steven J.M. Jones, Marjoleen Nijsen, René Rijnbrand, Paul S. Charifson, Michael P. Clark, Joshua R. Leeman, Edgar Schuck, Randal A. Byrn, Mark W. Ledeboer and Mark Penney and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Alice Tsai

11 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice Tsai United States 8 171 167 75 71 68 11 464
Holly Kimko United States 14 144 0.8× 95 0.6× 52 0.7× 94 1.3× 57 0.8× 38 587
Valérie Cosson Switzerland 12 108 0.6× 154 0.9× 86 1.1× 157 2.2× 56 0.8× 25 725
Efthymios Manolis Netherlands 12 84 0.5× 110 0.7× 93 1.2× 43 0.6× 61 0.9× 18 595
Jiuhong Zha United States 13 151 0.9× 99 0.6× 79 1.1× 73 1.0× 36 0.5× 34 567
Linyong Xu China 12 113 0.7× 187 1.1× 93 1.2× 177 2.5× 55 0.8× 35 740
Mirjam N. Trame United States 14 46 0.3× 83 0.5× 61 0.8× 56 0.8× 43 0.6× 33 504
Venkateswaran C. Pillai United States 12 55 0.3× 106 0.6× 68 0.9× 151 2.1× 28 0.4× 22 487
Jia Guo United States 15 183 1.1× 188 1.1× 131 1.7× 81 1.1× 153 2.3× 43 757
Grant Langdon United Kingdom 12 167 1.0× 127 0.8× 89 1.2× 76 1.1× 101 1.5× 28 736
Masataka Katashima Japan 13 119 0.7× 108 0.6× 104 1.4× 89 1.3× 27 0.4× 46 513

Countries citing papers authored by Alice Tsai

Since Specialization
Citations

This map shows the geographic impact of Alice Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Tsai more than expected).

Fields of papers citing papers by Alice Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Tsai. The network helps show where Alice Tsai may publish in the future.

Co-authorship network of co-authors of Alice Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Tsai. A scholar is included among the top collaborators of Alice Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Tsai. Alice Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cottrell, Kevin M., Kimberly J. Briggs, Alice Tsai, et al.. (2025). Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion. Journal of Medicinal Chemistry. 68(5). 5097–5119. 7 indexed citations
2.
Zhang, Minjie, Alice Tsai, Kevin M. Cottrell, et al.. (2025). Abstract 2996: TNG462, an MTA-cooperative PRMT5 inhibitor, demonstrates strong efficacy in combination with clinically relevant targeted therapies in MTAP-null preclinical models. Cancer Research. 85(8_Supplement_1). 2996–2996. 1 indexed citations
3.
Cottrell, Kevin M., Kimberly J. Briggs, Douglas A. Whittington, et al.. (2024). Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP-Deleted Cancers. Journal of Medicinal Chemistry. 67(8). 6064–6080. 34 indexed citations
4.
Ahronian, Leanne G., Minjie Zhang, Alborz Bejnood, et al.. (2023). 870 CoREST inhibition by TNG260 increases expression of immunomodulatory genes in STK11-mutant cancer and sensitizes to immune checkpoint blockade. SHILAP Revista de lepidopterología. A969–A969. 1 indexed citations
5.
6.
Heimbach, Tycho, Yuan Chen, Jun Chen, et al.. (2020). Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective. Clinical Pharmacology & Therapeutics. 110(2). 297–310. 91 indexed citations
7.
Spilker, Mary E., Richard Zang, Handan He, et al.. (2019). Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities. CPT Pharmacometrics & Systems Pharmacology. 8(11). 777–791. 60 indexed citations
8.
Nijsen, Marjoleen, Erica L. Bradshaw‐Pierce, Jason R. Chan, et al.. (2018). Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape. CPT Pharmacometrics & Systems Pharmacology. 7(3). 135–146. 64 indexed citations
9.
Wong, Harvey, Tonika Bohnert, Christopher R. Gibson, et al.. (2017). Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective. Drug Discovery Today. 22(10). 1447–1459. 22 indexed citations
10.
Tsai, Alice, Joshua R. Leeman, Kwame Nti-Addae, et al.. (2015). Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors. Antimicrobial Agents and Chemotherapy. 59(10). 6007–6016. 9 indexed citations
11.
Byrn, Randal A., Steven J.M. Jones, Michael P. Clark, et al.. (2014). Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit. Antimicrobial Agents and Chemotherapy. 59(3). 1569–1582. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Holly Kimko Breakdown of academic impact, for papers by Valérie Cosson Breakdown of academic impact, for papers by Efthymios Manolis Breakdown of academic impact, for papers by Jiuhong Zha Breakdown of academic impact, for papers by Linyong Xu Breakdown of academic impact, for papers by Mirjam N. Trame Breakdown of academic impact, for papers by Venkateswaran C. Pillai Breakdown of academic impact, for papers by Jia Guo Breakdown of academic impact, for papers by Grant Langdon Breakdown of academic impact, for papers by Masataka Katashima
Rankless by CCL
2026